If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Director/PDMR Shareholding

24 Jan 2023 15:09

RNS Number : 7310N
Renold PLC
24 January 2023
 

 

24 January 2023

 

Renold plc

("Renold" or the "Company")

 

Director/PDMR Shareholding

 

Renold plc, a leading international supplier of industrial chains and related power transmission products, announces the exercise of share options under the Company's 2013 Performance Share Plan by Robert Purcell, Chief Executive of the Company.

 

Robert Purcell exercised nil cost options over 1,065,089 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares"). The exercise of options will be satisfied by the transfer to Mr Purcell of 1,065,089 Ordinary Shares from the Renold Employee Benefit Trust.

 

Following this transaction, Mr Purcell, including the beneficial holdings of persons closely associated with him, has an interest in 5,808,878 Ordinary Shares, representing 2.58% of the Company's issued ordinary share capital.

 

ENQUIRIES:

Renold plc 

0161 498 4500

Robert Purcell, Chief Executive

 

Jim Haughey, Group Finance Director

 

 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

020 7418 8900

 

Mike Bell

 

 

Ed Allsopp

 

 

 

finnCap Limited (Joint Broker)

020 7220 0500

 

Ed Frisby / Tim Harper (Corporate Finance)

 

 

Andrew Burdis / Harriet Ward (ECM)

 

 

 

 

IFC Advisory Limited (Financial PR and IR)

020 3934 6630

 

Tim Metcalfe

renold@investor-focus.co.uk

 

Graham Herring

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Purcell

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

 

b)

LEI

213800LNDGJY65SP6P54

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: GB0007325078

b)

Nature of the transaction

Exercise of nil cost Company Share Option Plan options (granted in 2016) over Ordinary Shares in Renold Plc

c)

 

Price(s) and volume(s)

Exercise Price

Volume

Nil

1,065,089

d)

 

Aggregated information

- Aggregated volume

1,065,089 Ordinary Shares

- Price

 Nil

e)

 

Date of the transaction

 

24 January 2023

f)

 

Place of the transaction

 

Outside of a trading platform

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDBRGDDGXS
Date   Source Headline
8th May 20132:27 pmRNSHolding(s) in Company
2nd May 20135:47 pmRNSNotification of major interest in shares
2nd May 20134:40 pmRNSSecond Price Monitoring Extn
2nd May 20134:35 pmRNSPrice Monitoring Extension
1st May 20134:40 pmRNSSecond Price Monitoring Extn
1st May 20134:35 pmRNSPrice Monitoring Extension
1st May 20137:00 amRNSTrading Update
10th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 20135:09 pmRNSDirector/PDMR Shareholding
26th Mar 20132:45 pmRNSRe: Pensions Scheme
27th Feb 20137:00 amRNSDirector/PDMR Shareholding
14th Feb 20137:00 amRNSInterim Management Statement
30th Jan 201311:02 amRNSDirector/PDMR Shareholding
21st Jan 20135:08 pmRNSDirector/PDMR Shareholding
21st Jan 201312:31 pmRNSDirectorate Matters
31st Dec 201212:40 pmRNSSecond Price Monitoring Extn
31st Dec 201212:35 pmRNSPrice Monitoring Extension
21st Dec 20127:00 amRNSRe. Directorate Appointment
19th Dec 20124:41 pmRNSSecond Price Monitoring Extn
19th Dec 20124:35 pmRNSPrice Monitoring Extension
10th Dec 20124:40 pmRNSSecond Price Monitoring Extn
10th Dec 20124:35 pmRNSPrice Monitoring Extension
3rd Dec 20122:14 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Nov 20121:47 pmRNSNotification of major interest in shares
26th Nov 20121:03 pmRNSDirector/PDMR Shareholding
20th Nov 20127:00 amRNSHalf Yearly Report
12th Nov 20124:40 pmRNSSecond Price Monitoring Extn
12th Nov 20124:35 pmRNSPrice Monitoring Extension
26th Oct 20127:00 amRNSDirector Declaration
10th Oct 20124:40 pmRNSSecond Price Monitoring Extn
10th Oct 20124:35 pmRNSPrice Monitoring Extension
4th Oct 20127:00 amRNSNew Bank Facilities & Trading Update
21st Sep 20124:05 pmRNSHolding(s) in Company
7th Aug 20129:55 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSInterim Management Statement
1st Aug 20127:01 amRNSBlocklisting Interim Review
1st Aug 20127:00 amRNSBlocklisting Interim Review
16th Jul 20124:40 pmRNSSecond Price Monitoring Extn
16th Jul 20124:35 pmRNSPrice Monitoring Extension
12th Jul 20123:44 pmRNSResult of AGM
6th Jul 20125:07 pmRNSAnnual Report and Accounts
8th Jun 20123:41 pmRNSDirector/PDMR Shareholding
6th Jun 20127:00 amRNSDirector/PDMR Shareholding
31st May 20121:33 pmRNSDirector/PDMR Shareholding
31st May 20121:33 pmRNSDirector/PDMR Shareholding
29th May 20127:00 amRNSFinal Results
23rd May 20124:40 pmRNSSecond Price Monitoring Extn
23rd May 20124:35 pmRNSPrice Monitoring Extension
23rd May 201210:14 amRNSReplacement- Exercise of Share Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.